Coverage and Management of Medications for Treating Substance Abuse in Health Plans
description
Transcript of Coverage and Management of Medications for Treating Substance Abuse in Health Plans
Coverage and Management of Medications for Treating Substance Abuse in Health Plans
Constance M. Horgan, Sc.D.Sharon Reif, Ph.D.Dominic Hodgkin, Ph.D.Deborah W. Garnick, Sc.D.Elizabeth L. Merrick, Ph.D.
Institute for Behavioral Health, Schneider InstitutesThe Heller School for Social Policy and ManagementBrandeis University
AcademyHealth Annual Meeting, June 2006Supported by NIDA (R01 DA10915) and NIAAA (R01 AA10869)
Why Consider Medications for Substance Use Disorders?
• Important clinical advances in the pharmacological treatment of addiction and increasing availability of SA meds for consumers
• Prescription benefits can affect
– Access to medications for substance use disorders
– Cost of medications for substance use disorders
• Extent of restrictions influencing true availability to consumers in private health plans is unknown
Institute for Behavioral Health
Research Questions
• Which medications are excluded from coverage or placed on the costliest tier?
• How common are administrative controls, such as prior authorization?
• What plan characteristics are associated with use of each approach?– More managed plans (e.g. HMO) vs. others– Whether the plan contracts out for specialty
behavioral health (carve-out)
Institute for Behavioral Health
Study Overview
• Telephone survey of 368 health plans regarding 812 commercial managed care products for 2003; response rate = 83%
• Coordinated with RWJF’s Community Tracking Study (CTS)
• Focus on provision of alcohol, drug, and mental health services – administrative and clinical modules; typically 2 respondents per health plan
• Designed to produce national estimates• Survey administered by Mathematica Policy
Research
Institute for Behavioral Health
Research Domains
Administrative Module• Plan characteristics
• Contract arrangements
• Benefit design
• Provider payment methods
• Network management
• Enrollment and utilization
Clinical Module• Screening and primary
care
• Entry into specialty treatment
• Specialty treatment approaches
• Quality assurance
• Prescription drugs
Institute for Behavioral Health
Measures of Medication Management
Approach to specific medications can include:
• Exclusion from coverage
• Highest tier coverage on 3-Tier formularies
– Tier 1: lowest co-payment, usually generic meds
– Tier 2: middle co-payment, usually preferred brands
– Tier 3: highest co-payment, non-preferred brands
• Prior authorization requirement
Institute for Behavioral Health
Medications Studied
Alcohol DependenceNaltrexone (generic)Revia (brand name naltrexone)Antabuse (disulfiram)
Opioid DependenceSuboxone (buprenorphine/naloxone)Subutex (buprenorphine)*Methadone**
Institute for Behavioral Health
* Subutex results paralled Suboxone results, so are not shown**Methadone coverage examined in the context of treatment services; it is not a covered benefit for 48% of private health plans
What is the Pattern of Exclusion and 3-Tier Usage for SA Medications?
Institute for Behavioral Health
6 6
31
41
28
55
52
92
71
14
0%
20%
40%
60%
80%
100%
Tiers 1 or 2
Tier 3
Excluded
Revia Naltrexone Antabuse Suboxone
Percent of Plans
How Often is Tier 3 Used for SA Medications? **if medication is covered
44
2
28
80
0
20
40
60
80
100
ReviaNaltrexoneAntabuse
Suboxone
Institute for Behavioral HealthPercent of Plans with Medication on Tier 3
Alcohol Opiate
How Often is Prior Authorization Required for SA Medications? **if medication is covered
0
3
7
2
0
4
8
12
16
20
Revia
Naltrexone
Antabuse
Suboxone
Insitute for Behavioral Health
Percent of Plans Requiring Prior AuthorizationAlcohol Opiate
519
519
9
43
51
29 17
52
29
71 7581
93
0%
20%
40%
60%
80%
100%
Specia
lty
Inte
rnal
Specia
lty
Inte
rnal
Specia
lty
Inte
rnal
Tiers 1 or 2Tier 3Excluded
What is the Coverage Pattern for Alcohol Medications, by Contracting Arrangements?
Institute for Behavioral Health
Revia Naltrexone Antabuse
Percent of Plans
What is the Coverage Pattern for Alcohol Medications, by Product Type?
Institute for Behavioral Health
94 7 9 4 7
3838
50
24 2733
5359
43
75 7267
939490
0%
20%
40%
60%
80%
100%
HMO POS PPO HMO POS PPO HMO POS PPO
Tiers 1 or 2
Tier 3
Excluded
Revia Naltrexone Antabuse
Percent of Plans
What is the Coverage Pattern for Opiate Medications by Contracting Arrangements and Product Type?
Institute for Behavioral Health
36
19
3946
6
57
63
5146
69
718
10 8
25
0%
20%
40%
60%
80%
100%
Specialty Internal HMO POS PPO
Tiers 1 or 2
Tier 3
Excluded
Suboxone
Percent of Plans
Conclusions
• Exclusions– Rare for alcohol dependence medications– Buprenorphine excluded by 1/3 of products– Little variation by product type or contracting
• Tier 3– Common for alcohol dependence medications– Frequent for buprenorphine – Little variation by product type or contracting
• Prior authorization– Used rarely– More likely buprenorphine – Less likely for specialty contracts
Center for Behavioral Health
Implications
• Access to SA medications is limited depending on prescription benefit structure
• Inclusion on formularies is necessary for use of SA medications to be a viable treatment option
• Placement of SA medications on higher tiers may financially restrict access to SA medications for consumers in private plans
• Prior authorization, common in public plans, is rarely used in private plans
Center for Behavioral Health